|
15 Sep 2025 |
Torrent Pharma
|
Consensus Share Price Target
|
3531.60 |
3929.42 |
- |
11.26 |
buy
|
|
|
|
|
31 May 2023
|
Torrent Pharma
|
Prabhudas Lilladhar
|
3531.60
|
1900.00
|
1835.80
(92.37%)
|
Target met |
Buy
|
|
|
|
|
17 Mar 2023
|
Torrent Pharma
|
Sharekhan
|
3531.60
|
1788.00
|
1534.00
(130.22%)
|
Target met |
Buy
|
|
|
|
|
27 Jan 2023
|
Torrent Pharma
|
ICICI Direct
|
3531.60
|
1720.00
|
1537.40
(129.71%)
|
Target met |
Hold
|
|
|
|
|
27 Jan 2023
|
Torrent Pharma
|
ICICI Securities Limited
|
3531.60
|
1853.00
|
1556.75
(126.86%)
|
Target met |
Buy
|
|
|
Torrent Pharma’s (Torrent) Q3FY23 performance beats our estimates on all parameters. Revenue grew 18.3% YoY to Rs24.9bn (I-Sec: Rs23.3bn) led by 17.4% growth in India and 35.5% growth in Brazil.
|
|
03 Nov 2022
|
Torrent Pharma
|
Geojit BNP Paribas
|
3531.60
|
1819.00
|
1666.90
(111.87%)
|
Target met |
Hold
|
|
|
|
|
25 Oct 2022
|
Torrent Pharma
|
Prabhudas Lilladhar
|
3531.60
|
1850.00
|
1599.65
(120.77%)
|
Target met |
Buy
|
|
|
|
|
25 Oct 2022
|
Torrent Pharma
|
ICICI Securities Limited
|
3531.60
|
1853.00
|
1567.30
(125.33%)
|
Target met |
Buy
|
|
|
Torrent Pharma’s (Torrent) Q2FY23 performance was broadly in line with our estimates with revenue growing 7.2% YoY to Rs22.9bn and EBITDA margin at 29.6% (I-Sec: 30%). India grew 12.6% YoY while Brazil grew 18.6% YoY.
|
|
22 Oct 2022
|
Torrent Pharma
|
ICICI Direct
|
3531.60
|
1690.00
|
1573.60
(124.43%)
|
Target met |
Hold
|
|
|
|
|
29 Sep 2022
|
Torrent Pharma
|
ICICI Securities Limited
|
3531.60
|
1769.00
|
1494.30
(136.34%)
|
Target met |
Buy
|
|
|
Torrent Pharma (Torrent) is acquiring Curatio Healthcare Private Limited for a purchase consideration of Rs20bn.
|
|
28 Sep 2022
|
Torrent Pharma
|
ICICI Direct
|
3531.60
|
1730.00
|
1591.70
(121.88%)
|
Target met |
Buy
|
|
|
|